Miguel Arcinas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ex-Celgene CEO takes the top job at TORL—Chutes & Ladders

Ex-Celgene CEO takes the top job at TORL—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United statesDeepika jalotaAdi hoessMarc fellousMax bayerMolly gibsonDaiichi sankyoHans moebiusRobert califfPaolo martiniJulie tierneyRamin farzanehAdam perlmanRob scottCelia linAbionyx pharma

Capstan Therapeutics Appoints Ramin Farzaneh-Far, M D , as Chief Medical Officer and Announces Key Business Leadership Promotion

SAN DIEGO (BUSINESS WIRE) Jan 8, 2024

United kingdomSan franciscoUnited statesRhiannon jeselonisLos angelesRamin farzanehMiguel arcinasLaura shawverGilead sciencesUniversity of californiaIra pharmaceuticalsUniversity of chicago booth school businessCapstan therapeutics incCorporate developmentUniversity college londonUniversity of cambridge

Capstan Therapeutics to Participate in Upcoming Industry Conferences

Capstan Therapeutics to Participate in Upcoming Industry Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMiguel arcinasRhiannon jeselonisCapstan therapeutics incLeerink partners biopharma private companyCorporate developmentGenetic medicine summitScientific officerExecutive vice presidentAdrian botBeyond cancerGene meetingPark hyatt aviara resortSpotlight seriesCapstan therapeutics

Silverback Therapeutics (SBTX) to Merge with ARS Pharmaceuticals

Silverback Therapeutics (SBTX) to Merge with ARS Pharmaceuticals
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoLaura shawverMiguel arcinasCaroline cunninghamPorter novelliJustin chakmaRichard lowenthalCanale communicationsDrug administrationPharmaceuticals incSilverback therapeutics incNasdaq capital marketNew drug applicationSilverback therapeuticsInvestor relations

Silverback Therapeutics, Inc : Silverback Therapeutics Presents Interim Clinical Results from the Ongoing Phase 1/1b Study of SBT6050 Alone or In Combination with Pembrolizumab in Patients with Advanced or Metastatic HER2-Expressing Solid Tumors

- Proof-of-mechanism established with activation of myeloid and T/NK cells, and evidence of SBT6050 payload localization in the tumor microenvironment - SBT6050 demonstrated a manageable safety

United statesLaura shawverMiguel arcinasSamuel klempnerExchange commissionEuropean society for medical oncology congressCanale communicationsSilverback therapeutics incMedical oncologyMedical oncologistMassachusetts generalஒன்றுபட்டது மாநிலங்களில்லாரா சால்வர்பரிமாற்றம் தரகுஐரோப்பிய சமூகம் க்கு மருத்துவ புற்றுநோயியல் காங்கிரஸ்கால்வாய் தகவல்தொடர்புகள்